SAB Biotherapeutics, Inc. (SABS)
2.95
+0.01
(+0.34%)
USD |
NASDAQ |
Nov 06, 10:06
SAB Biotherapeutics Market Cap : 246.30M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 245.47M |
| November 04, 2026 | 265.51M |
| November 03, 2026 | 260.50M |
| November 02, 2026 | 275.53M |
| October 30, 2026 | 279.70M |
| October 29, 2026 | 269.68M |
| October 28, 2026 | 267.18M |
| October 27, 2026 | 256.32M |
| October 26, 2026 | 232.95M |
| October 23, 2026 | 237.12M |
| October 22, 2026 | 253.82M |
| October 21, 2026 | 235.45M |
| October 20, 2026 | 240.46M |
| October 19, 2026 | 217.08M |
| October 16, 2026 | 211.24M |
| October 15, 2026 | 216.25M |
| October 14, 2026 | 207.90M |
| October 13, 2026 | 223.76M |
| October 12, 2026 | 236.29M |
| October 09, 2026 | 248.81M |
| October 08, 2026 | 241.30M |
| October 07, 2026 | 240.46M |
| October 06, 2026 | 244.63M |
| October 05, 2026 | 258.83M |
| October 02, 2026 | 248.81M |
| Date | Value |
|---|---|
| October 01, 2026 | 255.49M |
| September 30, 2026 | 264.67M |
| September 29, 2026 | 268.85M |
| September 28, 2026 | 268.43M |
| September 25, 2026 | 274.69M |
| September 24, 2026 | 279.70M |
| September 23, 2026 | 283.04M |
| September 22, 2026 | 292.23M |
| September 21, 2026 | 283.04M |
| September 18, 2026 | 293.06M |
| September 17, 2026 | 292.23M |
| September 16, 2026 | 283.04M |
| September 15, 2026 | 284.71M |
| September 14, 2026 | 288.89M |
| September 11, 2026 | 284.71M |
| September 10, 2026 | 285.55M |
| September 09, 2026 | 290.56M |
| September 08, 2026 | 303.08M |
| September 04, 2026 | 310.59M |
| September 03, 2026 | 310.59M |
| September 02, 2026 | 313.10M |
| September 01, 2026 | 308.92M |
| August 31, 2026 | 309.76M |
| August 28, 2026 | 316.44M |
| August 27, 2026 | 328.13M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.121B |
| Oncolytics Biotech, Inc. | 56.65M |
| Sangamo Therapeutics, Inc. | 47.23M |
| Sarepta Therapeutics, Inc. | 1.861B |
| Anixa Biosciences, Inc. | 104.45M |
Market Cap Related Metrics
| Price to Book Value | 1.147 |
| Price | 2.95 |
| Earnings Yield | -49.07% |